SNYR Stock Forecast & Price Target

Synergy CHC Corp reported net revenues of $8.0 million, reflecting a 12% year-over-year increase, driven by a favorable shift toward higher-margin supplement revenues. Significant growth is anticipated in the FOCUSfactor brand, which has expanded from 3 to over 34 SKUs since its acquisition in 2015, indicating a strong potential for continued sales growth through new and existing retail partnerships. The company is expected to enhance its visibility into future financial performance, including sales and profits, through potential capital raising initiatives that could benefit current shareholders as they facilitate the achievement of sales, commercialization, and product development goals.

Synergy CHC Corp has experienced a significant shortfall in revenue expectations, leading to an Adjusted EBITDA of $1.3 million, which is flat compared to the previous year and markedly lower than the estimated $2.4 million. The company’s full-year revenue estimates have been revised downwards for 2025, 2026, and 2027, reflecting a troubling trend amid deteriorating economic conditions that typically curtail consumer spending. Furthermore, the company's share price has shown weakness and volatility over the past year, contributing to heightened uncertainty around its financial outlook.